Introducing
Your new presentation assistant.
Refine, enhance, and tailor your content, source relevant images, and edit visuals quicker than ever before.
Trending searches
Digestion (2,3)
Immunity (2,3)
Neurological impairments (2,3)
Vision (2,3)
Orthopaedics (2,3)
Clinical symptoms (4)
Molecular testing (4)
Positional Cloning
Figure 1. Positional cloning of the AT candidate gene.(5)
Gene expression
Figure 2. Expression of the ATM gene. A 5-kb 12- probe spanning the ORF of the 7-9 cDNA was hybridized to RNA.(5)
Figure 3. Amino acid sequence (50) of the deduced translation product encoded by the ORF in cDNA clone 7-9, beginning with the first available methionine residue.(5)
Identfied mutations
Table 1. Mutations identified in the ATM gene in AT patients.(5)
Figure 4. Schematic diagram of representative Pl-3 kinases.(5)
Figure 5. A deletion in the gene corresponding to the 7-9 transcript in family ISAT 9.(5)
ATM sequences scanned
Table 2. ATM Sequence Scanned.(6)
Mutations detected
Table 3. Mutations Detected in A-T Patients and Obligate Carriers.(6)
Mutant alleles detected
Table 4. ATM Mutant Alleles in A-T Patients and Carriers.(6)
Polymorphisms detected
Table 5. ATM Polymorphisms Detected.(6)
Cellular pathway (cell cycle regulation)
Figure 6. Overview of ATM and ATR dependent DNA damage induced cell cycle checkpoint signalling.(7)
Founders effect (2)
Autosomal Recessive (2)
Incidence ranges from 1:40,000 to 1:100,000 (2)
Gene Therapy
Expressing functional protein
Figure 7. Construction and expression of a lentiviral vector containing a normal ATM cDNA.(8)
Figure 8. Accumulation of p-ATM foci in A-T HIFs transduced with the lentiviral vector ThATM.(8)
Repairing irradiation-induced DSBs
Figure 9. Foci formation of p-p53 in WT and A-T HIFs transduced with the ThATM lentiviral vector.(8)
Research Directions
References
1. Gatti RA, Bick M, Tam CF, Medici MA, Oxelius V-A, Holland M, et al. Ataxia-telangiectasia: A multiparameter analysis of eight families. Clinical Immunology and Immunopathology. 1982 Dec 29;23(2):501–16. doi:10.1016/0090-1229(82)90134-9
2. Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: A Review. Orphanet Journal of Rare Diseases. 2016 Nov 25;11(1). doi:10.1186/s13023-016-0543-7
3. BioRENDER. Scientific Image and Illustration Software [Internet]. 2023 [cited 2023 Oct 12]. Available from: https://www.biorender.com/
4. Gatti RA. Ataxia-telangiectasia. Dermatologic Clinics. 1995 Mar 23;13(1):1–6. doi:10.1016/s0733-8635(18)30100-1
5. Gern JE. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Pediatrics. 1996 Apr 1;98(2):350–350. doi:10.1542/peds.98.2.350a
6. Buzin CH, Gatti RA, Nguyen VQ, Wen CY, Mitui M, Sanal O, et al. Comprehensive scanning of theatm gene with Dovam-S. Human Mutation. 2003 Aug 9;21(2):123–31. doi:10.1002/humu.10158
7. Weber AM, Ryan AJ. ATM and ATR as therapeutic targets in cancer. Pharmacology & Therapeutics. 2015 Dec 1;149:124–38. doi:10.1016/j.pharmthera.2014.12.001
8. Carranza D, Torres-Rusillo S, Ceballos-Pérez G, Blanco-Jimenez E, Muñoz-López M, García-Pérez JL, et al. Reconstitution of the ataxia-telangiectasia cellular phenotype with lentiviral vectors. Frontiers in Immunology. 2018 Aug 20;9. doi:10.3389/fimmu.2018.02703
9. Hwang M, Jun DW, Song BR, Shim H, Lee C-H, Kim S. Ataxia-telangiectasia mutated is involved in Autolysosome Formation. Biomolecules & Therapeutics. 2023 Mar 21;31(5):559–65. doi:10.4062/biomolther.2023.003